Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ganoderic acid F exhibits antitumor and antimetastatic activities through inhibition of angiogenesis and alteration of proteins involving cell proliferation and/or cell death, carcinogenesis, oxidative stress, calcium signaling, and endoplasmic reticulum
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 30,000 | |||
5 mg | 在庫あり | ¥ 73,000 | |||
10 mg | 在庫あり | ¥ 114,000 | |||
25 mg | 在庫あり | ¥ 182,000 | |||
50 mg | 在庫あり | お問い合わせ | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 91,500 |
ターゲット&IC50 | Proliferation:19.5±0.6 μM |
In vitro | Ganoderic acid F exhibits antitumor and antimetastatic activities through inhibition of angiogenesis and alteration of proteins involving cell proliferation and/or cell death, carcinogenesis, oxidative stress, calcium signaling, and endoplasmic reticulum stress. Ganoderic acid F is a ganoderic acid. |
植物由来 |
分子量 | 570.67 |
分子式 | C32H42O9 |
CAS No. | 98665-15-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (175.23 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ganoderic acid F 98665-15-7 Others cells proliferation HeLa inhibit antitumor carcinoma activities acid Inhibitor ganoderic human,cervical antimetastatic inhibitor